alpha-Particle Emitting Activity [MoA] - N0000187052

Name: Table of NDC products with alpha-particle emitting activity
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000187052
Pharmacologic Name	alpha-Particle Emitting Activity
Pharmacologic Uses	alpha particle-emitting radioactive therapeutic agent
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with alpha-Particle Emitting Activity

The table contains 1 products whose active ingredient are classified under the same pharmacologic class alpha-Particle Emitting Activity [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50419-208	Xofigo	Non-Proprietary Name: Radium Ra 223 Dichloride	Injection	Intravenous	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE